ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
PRNewsWire
·
2026-05-23
·
via The Tech Buzz - Press Releases
IBRX Investors with Losses Encouraged to Contact the Firm Before May 26th Deadline SAN FRANCISCO, May 23, 202…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。